New drug trial aims to help kids with rare hormone disorder use less steroids
NCT ID NCT07159841
Summary
This study is testing an investigational drug called atumelnant in children aged 1 to 18 with a genetic hormone disorder called congenital adrenal hyperplasia (CAH). The main goals are to see if the drug is safe, if it can help control abnormal hormone levels, and if it allows children to take lower doses of their current steroid medications. The trial includes an initial testing phase and a longer-term extension where participants can continue receiving the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL ADRENAL HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AOU Federico II
RECRUITINGNaples, Campania, 80131, Italy
-
Azienda Ospedaliera Universitaria Meyer IRCCS
RECRUITINGFlorence, Tuscany, 50139, Italy
-
Cook Children's Health Care System
RECRUITINGFort Worth, Texas, 76104, United States
-
Hopital Kremlin-Bicétre - APHP Paris Saclay
RECRUITINGLe Kremlin-Bicêtre, 94270, France
-
Hopital Robert Debre
RECRUITINGParis, 75019, France
-
Hospital Italiano de Buenos Aires
RECRUITINGBuenos Aires, C1199ABB, Argentina
-
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP)
RECRUITINGSão Paulo, São Paulo, 05403-000, Brazil
-
Institute of Endocrinology of Diabetes, The Children's Hospital at Westmead
NOT_YET_RECRUITINGWestmead, New South Wales, 2145, Australia
-
Instituto Médico Especializado (IME)
RECRUITINGBuenos Aires, C1405BCH, Argentina
-
Monash Children's Hospital, Monash Health
RECRUITINGClayton, Victoria, 3168, Australia
-
Queensland Children's Hospital
NOT_YET_RECRUITINGSouth Brisbane, Queensland, 4101, Australia
-
Rutgers Robert Wood Johnson Medical School
RECRUITINGNew Brunswick, New Jersey, 08901, United States
-
UZ Leuven (Universitair Ziekenhuis Leuven)
RECRUITINGLeuven, Flemish Brabant, 3000, Belgium
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55454, United States
-
University of Virginia Health System
RECRUITINGCharlottesville, Virginia, 22903, United States
-
Uniwersytecki Szpital Kliniczny Nr 1 im. Prof. Tadeusza Sokotowskiego PUM w Szczecinie, Centrum Wsparcia Badan Klinicznych Pomorskiego Uniwersytetu Medycznego w Szczecinie
RECRUITINGSzczecin, West Pomeranian Voivodeship, 71-252, Poland
-
lnstytut Centrum Zdrowia Matki Polki, Klinika Endokrynologii i Chor6b Metabolicznych
RECRUITINGLodz, Poland, 93-338, Poland
Conditions
Explore the condition pages connected to this study.